In a recent collaboration, Quest, Ibex, and Proscia ran a feasibility study* designed to understand how AI-powered diagnostics, delivered through an enterprise digital pathology platform, would impact operations in a large diagnostic lab setting. An overview of the results showed that:
Download the full report to dive deeper into the study goals, methodology, and results.
Read the report to find out how AI-powered digital pathology can transform routine diagnostic practice.
Figure 1: Example of digitized slide of a PCNB tissue sample (WSI) for review in the Concentriq Dx DP workflow (no AI overlay).
Figure 2: Example of digitized slide of a PCNB tissue sample (WSI) in the Concentriq Dx DP workflow with Ibex Prostate AI overlay highlighting the high cancer likelihood areas.
Proscia is a software company accelerating pathology’s transition to digital to change the way we understand diseases like cancer. Its Concentriq enterprise pathology platform and powerful AI applications are unlocking new insights that accelerate R&D, improve patient outcomes, and fulfill the promise of precision medicine.